Literature DB >> 33430178

Association between ApoE ε4 Carrier Status and Cardiovascular Risk Factors on Mild Cognitive Impairment among Mexican Older Adults.

Sara G Aguilar-Navarro1,2, Itzel I Gonzalez-Aparicio2, José Alberto Avila-Funes1,3, Teresa Juárez-Cedillo4, Teresa Tusié-Luna5, Alberto Jose Mimenza-Alvarado1,2.   

Abstract

Mild cognitive impairment (MCI) (amnestic or non-amnestic) has different clinical and neuropsychological characteristics, and its evolution is heterogeneous. Cardiovascular risk factors (CVRF), such as hypertension, diabetes, or dyslipidemia, and the presence of the Apolipoprotein E ε4 (ApoE ε4) polymorphism have been associated with an increased risk of developing Alzheimer's disease (AD) and other dementias but the relationship is inconsistent worldwide. We aimed to establish the association between the ApoE ε4 carrier status and CVRF on MCI subtypes (amnestic and non-amnestic) in Mexican older adults. Cross-sectional study including 137 older adults (n = 63 with normal cognition (NC), n = 24 with amnesic, and n = 50 with non-amnesic MCI). Multinomial logistic regression models were performed in order to determine the association between ApoE ε4 polymorphism carrier and CVRF on amnestic and non-amnestic-MCI. ApoE ε4 carrier status was present in 28.8% participants. The models showed that ApoE ε4 carrier status was not associated neither aMCI nor naMCI condition. The interaction term ApoE ε4 × CVRF was not statistically significant for both types of MCI. However, CVRF were associated with both types of MCI and the association remained statistically significant after adjustment by sex, age, and education level. The carrier status of the ApoE genotype does not contribute to this risk.

Entities:  

Keywords:  Mexican Mestizo older adults; amnestic MCI; apolipoprotein E ε4; cardiovascular risk factors; non-amnestic MCI

Year:  2021        PMID: 33430178      PMCID: PMC7825603          DOI: 10.3390/brainsci11010068

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  35 in total

Review 1.  Mild cognitive impairment--a review of prevalence, incidence and outcome according to current approaches.

Authors:  J Bischkopf; A Busse; M C Angermeyer
Journal:  Acta Psychiatr Scand       Date:  2002-12       Impact factor: 6.392

Review 2.  Neurovascular and Cognitive Dysfunction in Hypertension.

Authors:  Costantino Iadecola; Rebecca F Gottesman
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

3.  Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.

Authors:  Danielle C Whitehair; Abdullah Sherzai; Jennifer Emond; Rema Raman; Paul S Aisen; Ronald C Petersen; Adam S Fleisher
Journal:  Alzheimers Dement       Date:  2010-09       Impact factor: 21.566

4.  Clinical and Demographic Predictors of Conversion to Dementia in Mexican Elderly with Mild Cognitive Impairment.

Authors:  Sara G Aguilar-Navarro; Alberto J Mimenza-Alvarado; José Alberto Ávila-Funes; Teresa Juárez-Cedillo; Carolina Bernal-López; Celia G Hernández-Favela
Journal:  Rev Invest Clin       Date:  2017 Jan-Feb       Impact factor: 1.451

Review 5.  Prevalence of Depression in Patients With Mild Cognitive Impairment: A Systematic Review and Meta-analysis.

Authors:  Zahinoor Ismail; Heba Elbayoumi; Corinne E Fischer; David B Hogan; Colleen P Millikin; Tom Schweizer; Moyra E Mortby; Eric E Smith; Scott B Patten; Kirsten M Fiest
Journal:  JAMA Psychiatry       Date:  2017-01-01       Impact factor: 21.596

6.  Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis.

Authors:  Diarmaid Hughes; Conor Judge; Robert Murphy; Elaine Loughlin; Maria Costello; William Whiteley; Jackie Bosch; Martin J O'Donnell; Michelle Canavan
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

Review 7.  Cholesterol and Alzheimer's Disease Risk: A Meta-Meta-Analysis.

Authors:  Olalla Sáiz-Vazquez; Alicia Puente-Martínez; Silvia Ubillos-Landa; Joaquín Pacheco-Bonrostro; Javier Santabárbara
Journal:  Brain Sci       Date:  2020-06-18

Review 8.  Depression, Anxiety, and Apathy in Mild Cognitive Impairment: Current Perspectives.

Authors:  Lina Ma
Journal:  Front Aging Neurosci       Date:  2020-01-30       Impact factor: 5.750

Review 9.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

Authors:  Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2020-07-30       Impact factor: 79.321

View more
  1 in total

1.  Mitochondrial DNA oxidative mutations are elevated in Mexican American women potentially implicating Alzheimer's disease.

Authors:  Danielle Marie Reid; Robert C Barber; Roland J Thorpe; Jie Sun; Zhengyang Zhou; Nicole R Phillips
Journal:  NPJ Aging       Date:  2022-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.